TY - JOUR
T1 - Advance Care Planning in Adults With Congenital Heart Diseases
T2 - Current Practices, Preferences, and Needs of 8,281 Adults From 32 Countries
AU - Van Bulck, Liesbet
AU - Goossens, Eva
AU - Kovacs, Adrienne H.
AU - Luyckx, Koen
AU - Ladak, Laila Akbar
AU - Leye, Mohamed
AU - Van De Bruaene, Alexander
AU - Leong, Ming Chern
AU - Kaneva, Anna
AU - Pavão, Rafael Brolio
AU - Araujo, John Jairo
AU - Sasikumar, Navaneetha
AU - Gabriel, Harald
AU - Goshu, Dejuma Yadeta
AU - Lu, Chun Wei
AU - Enomoto, Junko
AU - Areias, Maria Emília
AU - Kosmidis, Diamantis
AU - Coats, Louise
AU - Valente, Anne Marie
AU - Moon, Ju Ryoung
AU - Ladouceur, Magalie
AU - Thomet, Corina
AU - Jackson, Jamie L.
AU - Sandberg, Camilla
AU - Callus, Edward
AU - Kim, Yuli Y.
AU - Lykkeberg, Birgitte
AU - Alday, Luis
AU - Bredy, Charlene
AU - Saidi, Arwa
AU - Reyes, Fernando Baraona
AU - Menahem, Samuel
AU - de Hosson, Michèle
AU - Mandelenakis, Zacharias
AU - Christersson, Christina
AU - Zaidi, Ali
AU - Johansson, Bengt
AU - Andresen, Brith
AU - Ambassa, Jean Claude
AU - Mattsson, Eva
AU - Constantine, Andrew
AU - Amedro, Pascal
AU - van Melle, Joost P.
AU - Cedars, Ari
AU - Ortiz, Lucia
AU - Demir, Fatma
AU - Khairy, Paul
AU - Windram, Jonathan
AU - Bouchardy, Judith
AU - Caruana, Maryanne
AU - Jameson, Susan M.
AU - Mahadevan, Vaikom S.
AU - McGrath, Lidija B.
AU - Mwita, Julius Chacha
AU - Moons, Philip
N1 - Publisher Copyright:
© 2026 The Authors.
PY - 2026
Y1 - 2026
N2 - Background Adults with congenital heart disease (CHD) are at high risk of premature death, making advance care planning (ACP) crucial for aligning care with individual values and goals. Previous ACP research has focused primarily on the United States and Canada, highlighting the need for a global perspective. We aimed to describe the ACP practices, needs, and preferences of adults with CHD around the globe and to investigate associations with patient-related factors. Methods This cross-sectional study, part of the APPROACH-IS II project, assessed ACP preferences, needs, and practices by means of patient-reported surveys. Overall, 8281 patients with CHD (median age 32 years; 54% women; 15% mild, 58% moderate, 27% complex CHD) from 53 centres in 32 countries, spanning 6 continents, were included. Results More than one-half of participants (55%) reported speaking to their physician about how their health might be in the future and 9% had preferences being documented in a plan. According to 66% of patients, the best time to initiate ACP is early in the disease trajectory. Most patients indicated being relatively comfortable talking to their physician about their future health and about death. ACP varied widely across different countries, with the United States and Canada at the top of the class for most variables. Conclusions When looking at global ACP practices, needs, and preferences, much room for improvement of ACP provision could be noticed. Also, a notable variation in ACP was observed worldwide. Clinical Trial Registration: NCT04902768 .
AB - Background Adults with congenital heart disease (CHD) are at high risk of premature death, making advance care planning (ACP) crucial for aligning care with individual values and goals. Previous ACP research has focused primarily on the United States and Canada, highlighting the need for a global perspective. We aimed to describe the ACP practices, needs, and preferences of adults with CHD around the globe and to investigate associations with patient-related factors. Methods This cross-sectional study, part of the APPROACH-IS II project, assessed ACP preferences, needs, and practices by means of patient-reported surveys. Overall, 8281 patients with CHD (median age 32 years; 54% women; 15% mild, 58% moderate, 27% complex CHD) from 53 centres in 32 countries, spanning 6 continents, were included. Results More than one-half of participants (55%) reported speaking to their physician about how their health might be in the future and 9% had preferences being documented in a plan. According to 66% of patients, the best time to initiate ACP is early in the disease trajectory. Most patients indicated being relatively comfortable talking to their physician about their future health and about death. ACP varied widely across different countries, with the United States and Canada at the top of the class for most variables. Conclusions When looking at global ACP practices, needs, and preferences, much room for improvement of ACP provision could be noticed. Also, a notable variation in ACP was observed worldwide. Clinical Trial Registration: NCT04902768 .
KW - advance care planning
KW - congenital heart disease
KW - palliative care
UR - https://www.scopus.com/pages/publications/105029573037
U2 - 10.1016/j.cjca.2025.12.039
DO - 10.1016/j.cjca.2025.12.039
M3 - Article
C2 - 41519299
AN - SCOPUS:105029573037
SN - 0828-282X
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
ER -